Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Health Disparities Subcommittee (HDS), 53703 [2010-21803]

Download as PDF hsrobinson on DSK69SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cancer Immunotherapy. Date: September 30, 2010. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Syed M Quadri, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435– 1211, quadris@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Cardiovascular and Sleep Epidemiology Study Section. Date: October 7–8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: J. Scott Osborne, PhD, MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD 20892, (301) 435– 1782, osbornes@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. Date: October 7–8, 2010. Time: 8:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Michael M Sveda, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301–435– 3565, svedam@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Radiation Oncology. Date: October 7, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Syed M. Quadri, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435– 1211, quadris@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Urologic and Kidney Development and Genitourinary Diseases Study Section. Date: October 8, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. VerDate Mar<15>2010 18:24 Aug 31, 2010 Jkt 220001 Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Ryan G. Morris, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301–435– 1501, morrisr@csr.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Musculoskeletal Rehabilitation Sciences Study Section. Date: October 8, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314. Contact Person: Jo Pelham, BA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435–1786, pelhamj@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Host Interactions with Bacterial Pathogens Study Section. Date: October 8, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Fouad A El-Zaatari, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD 20892, (301) 435– 1149, elzaataf@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 26, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21815 Filed 8–31–10; 8:45 am] 53703 Place: The teleconference will originate at the CDC. Status: Open to the public. Teleconference access limited only by the availability of telephone ports. The public is welcome to participate during the public comment period, which is tentatively scheduled from 2:45 p.m. to 2:50 p.m. To participate in the teleconference please dial (877) 394–7734 and enter conference code 9363147. Purpose: The Subcommittee will provide recommendations for consideration to the Advisory Committee to the Director on strategic and other broad issues facing CDC. Matters to be Discussed: Policy brief on health equity and social determinants of health; update on collaboration with the CDC Health Equity Workgroup; CDC Director’s Annual Health Disparity Report; and briefing on the realignment of the CDC Office of Minority Health and Health Disparities. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Walter W. Williams, M.D., M.P.H., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S E–67, Atlanta, Georgia 30333. Telephone (404) 498–2310, E-mail: www1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: August 24, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–21803 Filed 8–31–10; 8:45 am BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned subcommittee: Time and Date: 2 p.m.–3 p.m., September 23, 2010. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Page 53703]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21803]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)--Health Disparities Subcommittee (HDS)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the CDC announces the following meeting 
of the aforementioned subcommittee:

    Time and Date: 2 p.m.-3 p.m., September 23, 2010.
    Place: The teleconference will originate at the CDC.
    Status: Open to the public. Teleconference access limited only 
by the availability of telephone ports. The public is welcome to 
participate during the public comment period, which is tentatively 
scheduled from 2:45 p.m. to 2:50 p.m. To participate in the 
teleconference please dial (877) 394-7734 and enter conference code 
9363147.
    Purpose: The Subcommittee will provide recommendations for 
consideration to the Advisory Committee to the Director on strategic 
and other broad issues facing CDC.
    Matters to be Discussed: Policy brief on health equity and 
social determinants of health; update on collaboration with the CDC 
Health Equity Workgroup; CDC Director's Annual Health Disparity 
Report; and briefing on the realignment of the CDC Office of 
Minority Health and Health Disparities.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Walter W. Williams, M.D., 
M.P.H., Designated Federal Officer, Health Disparities Subcommittee, 
Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S 
E-67, Atlanta, Georgia 30333. Telephone (404) 498-2310, E-mail: 
www1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: August 24, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-21803 Filed 8-31-10; 8:45 am
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.